CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
8,109,579
Share change
+658,393
Total reported value
$12,078,000
Price per share
$1.49
Number of holders
24
Value change
+$712,852
Number of buys
18
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q4 2017

As of 31 Dec 2017, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,109,579 shares. The largest 10 holders included SV Health Investors, LLC, Clarus Ventures, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, SPHERA FUNDS MANAGEMENT LTD., DEUTSCHE BANK AG\, Alyeska Investment Group, L.P., OPPENHEIMER & CO INC, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.